These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 17157007

  • 1. Synthesis of a novel inhibitor against MRSA and VRE: preparation from zerumbone ring opening material showing histidine-kinase inhibition.
    Kitayama T, Iwabuchi R, Minagawa S, Sawada S, Okumura R, Hoshino K, Cappiello J, Utsumi R.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):1098-101. PubMed ID: 17157007
    [Abstract] [Full Text] [Related]

  • 2. Unprecedented olefin-dependent histidine-kinase inhibitory of zerumbone ring-opening material.
    Kitayama T, Iwabuchi R, Minagawa S, Shiomi F, Cappiello J, Sawada S, Utsumi R, Okamoto T.
    Bioorg Med Chem Lett; 2004 Dec 06; 14(23):5943-6. PubMed ID: 15501073
    [Abstract] [Full Text] [Related]

  • 3. Study on in vivo effects of bacterial histidine kinase inhibitor, Waldiomycin, in Bacillus subtilis and Staphylococcus aureus.
    Fakhruzzaman M, Inukai Y, Yanagida Y, Kino H, Igarashi M, Eguchi Y, Utsumi R.
    J Gen Appl Microbiol; 2015 Dec 06; 61(5):177-84. PubMed ID: 26582287
    [Abstract] [Full Text] [Related]

  • 4. Antibacterial agents that inhibit histidine protein kinase YycG of Bacillus subtilis.
    Yamamoto K, Kitayama T, Minagawa S, Watanabe T, Sawada S, Okamoto T, Utsumi R.
    Biosci Biotechnol Biochem; 2001 Oct 06; 65(10):2306-10. PubMed ID: 11758928
    [Abstract] [Full Text] [Related]

  • 5. Isolation and characterization of inhibitors of the essential histidine kinase, YycG in Bacillus subtilis and Staphylococcus aureus.
    Watanabe T, Hashimoto Y, Yamamoto K, Hirao K, Ishihama A, Hino M, Utsumi R.
    J Antibiot (Tokyo); 2003 Dec 06; 56(12):1045-52. PubMed ID: 15015732
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test.
    Block C, Robenshtok E, Simhon A, Shapiro M.
    J Hosp Infect; 2000 Oct 06; 46(2):147-52. PubMed ID: 11049709
    [Abstract] [Full Text] [Related]

  • 7. Chemistry of zerumbone. 2. Regulation of ring bond cleavage and unique antibacterial activities of zerumbone derivatives.
    Kitayama T, Yamamoto K, Utsumi R, Takatani M, Hill RK, Kawai Y, Sawada S, Okamoto T.
    Biosci Biotechnol Biochem; 2001 Oct 06; 65(10):2193-9. PubMed ID: 11758909
    [Abstract] [Full Text] [Related]

  • 8. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
    Macielag MJ, Demers JP, Fraga-Spano SA, Hlasta DJ, Johnson SG, Kanojia RM, Russell RK, Sui Z, Weidner-Wells MA, Werblood H, Foleno BD, Goldschmidt RM, Loeloff MJ, Webb GC, Barrett JF.
    J Med Chem; 1998 Jul 30; 41(16):2939-45. PubMed ID: 9685233
    [Abstract] [Full Text] [Related]

  • 9. Syntheses and anti-MRSA activities of the C3 analogs of mansonone F, a potent anti-bacterial sesquiterpenoid: insights into its structural requirements for anti-MRSA activity.
    Shin DY, Kim SN, Chae JH, Hyun SS, Seo SY, Lee YS, Lee KO, Kim SH, Lee YS, Jeong JM, Choi NS, Suh YG.
    Bioorg Med Chem Lett; 2004 Sep 06; 14(17):4519-23. PubMed ID: 15357984
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeting protein homodimerization: a novel drug discovery system.
    Furuta E, Yamamoto K, Tatebe D, Watabe K, Kitayama T, Utsumi R.
    FEBS Lett; 2005 Apr 11; 579(10):2065-70. PubMed ID: 15811319
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA, Beaulieu S, Arhin FF, Belley A, Sarmiento I, Parr T, Moeck G.
    J Antimicrob Chemother; 2009 Jun 11; 63(6):1191-9. PubMed ID: 19369269
    [Abstract] [Full Text] [Related]

  • 17. Waldiomycin, a novel WalK-histidine kinase inhibitor from Streptomyces sp. MK844-mF10.
    Igarashi M, Watanabe T, Hashida T, Umekita M, Hatano M, Yanagida Y, Kino H, Kimura T, Kinoshita N, Inoue K, Sawa R, Nishimura Y, Utsumi R, Nomoto A.
    J Antibiot (Tokyo); 2013 Aug 11; 66(8):459-64. PubMed ID: 23632918
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Isolation and characterization of signermycin B, an antibiotic that targets the dimerization domain of histidine kinase WalK.
    Watanabe T, Igarashi M, Okajima T, Ishii E, Kino H, Hatano M, Sawa R, Umekita M, Kimura T, Okamoto S, Eguchi Y, Akamatsu Y, Utsumi R.
    Antimicrob Agents Chemother; 2012 Jul 11; 56(7):3657-63. PubMed ID: 22526318
    [Abstract] [Full Text] [Related]

  • 20. Structure-activity relationships of cephalosporin derivatives against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
    Hanaki H, Akagi H, Nomura S, Unemi N, Hiramatsu K.
    J Antibiot (Tokyo); 1996 Apr 11; 49(4):402-4. PubMed ID: 8642007
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.